These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 17010577
1. LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance. Barancík M, Bohácová V, Sedlák J, Sulová Z, Breier A. Eur J Pharm Sci; 2006 Dec; 29(5):426-34. PubMed ID: 17010577 [Abstract] [Full Text] [Related]
2. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity. Sulová Z, Macejová D, Seres M, Sedlák J, Brtko J, Breier A. Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233 [Abstract] [Full Text] [Related]
3. Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine. Xie X, Tang B, Zhou J, Gao Q, Zhang P. Oncol Rep; 2013 Aug; 30(2):773-82. PubMed ID: 23743572 [Abstract] [Full Text] [Related]
4. Multidrug resistant P-glycoprotein positive L1210/VCR cells are also cross-resistant to cisplatin via a mechanism distinct from P-glycoprotein-mediated drug efflux activity. Gibalová L, Sedlák J, Labudová M, Barancík M, Reháková A, Breier A, Sulová Z. Gen Physiol Biophys; 2009 Dec; 28(4):391-403. PubMed ID: 20097962 [Abstract] [Full Text] [Related]
5. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR. Tang XQ, Bi H, Feng JQ, Cao JG. Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636 [Abstract] [Full Text] [Related]
6. SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance. Barancík M, Bohácová V, Kvackajová J, Hudecová S, Krizanová O, Breier A. Eur J Pharm Sci; 2001 Aug; 14(1):29-36. PubMed ID: 11457647 [Abstract] [Full Text] [Related]
7. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR. Zhang Y, Qu XJ, Liu YP, Yang XH, Hou KZ, Teng YE, Zhang JD. Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116 [Abstract] [Full Text] [Related]
8. P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation. Gibalová L, Sereš M, Rusnák A, Ditte P, Labudová M, Uhrík B, Pastorek J, Sedlák J, Breier A, Sulová Z. Toxicol In Vitro; 2012 Apr; 26(3):435-44. PubMed ID: 22269388 [Abstract] [Full Text] [Related]
9. Potentiation of anticancer drugs: effects of pentoxifylline on neoplastic cells. Barancik M, Bohacova V, Gibalova L, Sedlak J, Sulova Z, Breier A. Int J Mol Sci; 2012 Apr; 13(1):369-82. PubMed ID: 22312258 [Abstract] [Full Text] [Related]
10. Cytotoxic activity of several unrelated drugs on L1210 mouse leukemic cell sublines with P-glycoprotein (PGP) mediated multidrug resistance (MDR) phenotype. A QSAR study. Breier A, Drobná Z, Docolomansky P, Barancik M. Neoplasma; 2000 Apr; 47(2):100-6. PubMed ID: 10985475 [Abstract] [Full Text] [Related]
11. Hyaluronan oligosaccharides sensitize lymphoma resistant cell lines to vincristine by modulating P-glycoprotein activity and PI3K/Akt pathway. Cordo Russo RI, García MG, Alaniz L, Blanco G, Alvarez E, Hajos SE. Int J Cancer; 2008 Mar 01; 122(5):1012-8. PubMed ID: 17985348 [Abstract] [Full Text] [Related]
12. beta(2)-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein. Wu CH, Rastegar M, Gordon J, Safa AR. Oncogene; 2001 Oct 25; 20(48):7006-20. PubMed ID: 11704825 [Abstract] [Full Text] [Related]
13. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process. Yu C, Rahmani M, Dai Y, Conrad D, Krystal G, Dent P, Grant S. Cancer Res; 2003 Apr 15; 63(8):1822-33. PubMed ID: 12702569 [Abstract] [Full Text] [Related]
14. Time dependence of [3H]-vincristine accumulation by L1210 mouse leukemic cells. Effect of P-glycoprotein overexpression. Breier A, Stefanková Z, Barancík M, Tribulová N. Gen Physiol Biophys; 1994 Aug 15; 13(4):287-98. PubMed ID: 7890145 [Abstract] [Full Text] [Related]
15. Direct interaction between verapamil and doxorubicin causes the lack of reversal effect of verapamil on P-glycoprotein mediated resistance to doxorubicin in vitro using L1210/VCR cells. Breier A, Drobná Z, Barancík M. Neoplasma; 1998 Aug 15; 45(4):248-53. PubMed ID: 9890669 [Abstract] [Full Text] [Related]
16. Effect of pentoxifylline on P-glycoprotein mediated vincristine resistance of L1210 mouse leukemic cell line. Breier A, Barancík M, Stefanková Z, Uhrík B, Tribulová N. Neoplasma; 1994 Aug 15; 41(5):297-303. PubMed ID: 7854500 [Abstract] [Full Text] [Related]
17. L1210 cells cultivated under the selection pressure of doxorubicin or vincristine express common mechanisms of multidrug resistance based on the overexpression of P-glycoprotein. Bohácová V, Sulová Z, Dovinová I, Poláková E, Barancík M, Uhrík B, Orlický J, Breier A. Toxicol In Vitro; 2006 Dec 15; 20(8):1560-8. PubMed ID: 16962737 [Abstract] [Full Text] [Related]
18. Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines. Badinloo M, Esmaeili-Mahani S. Fundam Clin Pharmacol; 2014 Aug 15; 28(4):414-22. PubMed ID: 23837575 [Abstract] [Full Text] [Related]
19. DJ-1 is involved in the multidrug resistance of SGC7901 gastric cancer cells through PTEN/PI3K/Akt/Nrf2 pathway. Qiu L, Ma Z, Li X, Deng Y, Duan G, Zhao LE, Xu X, Xiao L, Liu H, Zhu Z, Chen H. Acta Biochim Biophys Sin (Shanghai); 2020 Dec 11; 52(11):1202-1214. PubMed ID: 33079995 [Abstract] [Full Text] [Related]
20. Apoptosis induction of human leukemia cells by Streptomyces sp. SY-103 metabolites through activation of caspase-3 and inactivation of Akt. Jeong SY, Han MH, Jin CY, Kim GY, Choi BT, Nam TJ, Kim SK, Choi YH. Int J Mol Med; 2010 Jan 11; 25(1):31-40. PubMed ID: 19956899 [Abstract] [Full Text] [Related] Page: [Next] [New Search]